Handai Candesartan anti-atherogenesis Trial on diabetic patients with hypertension using CT examinatio
Not Applicable
- Conditions
- Type 2 diabetic patients with hypertension
- Registration Number
- JPRN-UMIN000001453
- Lead Sponsor
- Department of Metabolic Medicine, Graduate School of Medicine, Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Contraindications of candesartan 2)Contraindications of contrast agent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of metabolic parameters, oxidative stress markers, adipocytokines, visceral fat areas, quality and quantity of coronary plaque, and carotid intima-media complex thickness (IMT), at the completion of treatment form baseline
- Secondary Outcome Measures
Name Time Method